Here’s what you should know:
1. Five analyst firms made predictions on Valeant’s quarterly sales, the lowest estimate was $2.09 billion, while the highest was $2.24 billion.
2. If the estimates are correct, it shows Valeant sales decreased 9.6 percent year over year.
3. Valeant will announce its quarterly earnings Feb. 27.
4. Analysts anticipate full-year sales between $8.65 billion to $8.80 billion.
More articles on supply chain:
Campbell Clinic receives 8-year tax abatement for $30M expansion with ASC — 4 insights
Maximize your 2018 reimbursements: Know your health plans, know your market, and stay on top of trends
21 statistics on ASC accounts receivable
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
